• HOME
  • Business
  • Stock
  • Property
  • Market
  • Economy
  • Crypto
Language:
×
  • Home
  • tags Pharmaceuticals Division

Pharmaceuticals Division News

Business

Bayer AG Reports Steady Q1 Sales at €13.7 Billion Amidst Challenging Fiscal Year

Michael Lee 13 May, 2025

Bayer AG reports stable Q1 sales of €13.7 billion for fiscal 2025, with a significant drop in net income. The company reaffirms its 2025 guidance, highlighting growth in the Pharma...

Popular News

  • Economy

    EU Delays Countermeasures Against US Tariffs Until August Amid Trade Tensions

    14 Jul, 2025
  • Economy

    Trump Imposes 25% Tariffs on Mexico to Combat Drug Trafficking Crisis

    02 Feb, 2025
  • Business

    India Shines as a Beacon for Private Investments Amid Global Challenges: CII Survey Insights

    19 Jan, 2025
  • Business

    KEC International Achieves Major Milestone with Rs 1,034 Crore Orders in Power, Civil, and Cables Sectors

    12 May, 2025
  • Economy

    Hanoi Jobseekers Aim for $200-400 Monthly Salary Amidst Rising Job Openings

    09 Dec, 2024
  • Market

    Geopolitical Tensions and Economic Optimism Drive Crude Oil Prices Up by Over 1%

    18 Jul, 2025
  • Business

    India and EFTA Set to Launch Groundbreaking Trade Agreement This October, Announces Minister Goyal

    20 Jul, 2025
  • Business

    Bill Ackman's Pershing Square Makes a Bold $900 Million Investment in Howard Hughes Holdings

    06 May, 2025

Newsletter

Subscribe Newsletter!

Stay ahead of the market – subscribe now for the latest insights and expert analysis delivered straight to your inbox!

About Us

  • EconWatcher.com is a comprehensive financial website dedicated to providing insights into economics, stocks, real estate, cryptocurrencies, markets, and business trends.
  • 15 Cliff St, New York NY 10038, USA
  • +91 234 567 8765
  • [email protected]

Popular Categories

  • Business (1M+)
  • Stock (1M+)
  • Property (1M+)
  • Market (1M+)
  • Economy (1M+)
  • Crypto (1M+)

Legal

  • Privacy Policy

  • Terms & Conditions

  • Contact Us

Copyright © 2022 All Rights Reserved.